
Best Cord Blood Banks 2026: Top 5 Picks Ranked
July 7, 2026 · ParentRankings Editors
Our Top Pick

Cord Blood Registry (CBR)
CBR's 30+ years of operation, 900,000+ stored units, and more stem cell releases for actual treatment than any other private bank make it the most clinically proven choice — though parents should monitor the ongoing legal proceedings and fee transparency closely.
In February 2026, the Texas Attorney General filed a lawsuit against Cord Blood Registry, the largest private cord blood bank in the country. That filing didn't come out of nowhere. It followed a 2025 Arizona AG deceptive-practices lawsuit whose motion to dismiss was denied, and a federal class action investigation still underway over undisclosed storage fee increases. If you're in your third trimester right now and haven't locked in a cord blood bank yet, this is the landscape you're making that decision in.
We want to be clear about what this legal activity does and doesn't mean. There is no indication that stored samples are at risk. What these proceedings do signal is that fee transparency and business practices in this industry deserve scrutiny, not just trust. For years, cord blood banking has been marketed almost entirely on emotion, and not enough parents have been asking the harder questions: What are my total costs over 18 years? What is this bank's actual clinical track record? What happens if they raise my rates without notice?
This guide is built around those questions. We ranked five banks by accreditation, transplant track record, storage reliability, and real total cost so you can make a confident decision before your delivery date, not a rushed one.
What to Look for in a Cord Blood Bank
Accreditation and regulatory standing are the floor, not the ceiling. AABB and FACT accreditation mean an independent third party has actually audited a bank's collection, processing, and storage protocols. FDA registration is legally required, so it tells you almost nothing on its own. Every bank in our ranking holds recognized third-party accreditation. Given the current wave of legal scrutiny, we'd be skeptical of any bank that can't point to active AABB or FACT status.
Transplant track record is the most meaningful number in this entire category, and it's the one banks advertise least. How many times have stored units actually been released for treatment? A bank with thousands of documented releases has proven, in the real world, that its collection and storage processes preserve viable stem cells. A bank with a small or unpublished release history is asking you to trust their marketing instead of their results.
Total cost over 18 years is where parents most often get surprised. Enrollment fees are visible and easy to compare. Annual storage fees are where the math gets painful. A $100 difference in annual rates compounds to $1,800 over an 18-year banking period. More importantly, some banks have a documented history of raising those rates without adequate notice, which is precisely what the current federal class action investigation is about. A price-lock guarantee is no longer just a nice feature. At this moment in this industry, it's a legitimate risk-management tool.
Storage redundancy and facility safety determine whether your sample is actually usable when you need it, which could be decades from now. Dual-tank storage, backup power systems, and geographically secure facilities are the infrastructure that protects long-term viability. A bank that offers a sample viability guarantee or full refund is telling you something important: they're confident enough in their own storage quality to put money behind it. That kind of commitment is worth more than any marketing claim.
Scope of banking options is a forward-looking consideration. Cord blood banking is clinically established, with over 80 treatable conditions documented. Cord tissue and placenta tissue banking are earlier-stage, but the research is advancing. Banks that collect multiple tissue types in a single kit give families broader future coverage without requiring a second collection. If you're already going through the process, the incremental cost of banking additional tissue types is worth weighing against the potential upside as the science matures.
Who Should Buy
If clinical proof matters most to you, our top pick has the longest operating history and more stem cell releases for actual treatment than any other private bank. That track record is real and meaningful. Just go in with full awareness of the ongoing legal proceedings, read the current fee schedule carefully, and ask directly about rate-lock options.
If you want the broadest biological coverage, our best technology pick collects cord blood, cord tissue, and placenta tissue in a single kit at a lower annual storage rate than most competitors. It's the right call for parents who want to preserve options as the science evolves, even if the company's track record is shorter than the legacy players.
If personal support and a viability guarantee are your priorities, our best customer service pick assigns a dedicated family specialist to every account and backs its storage quality with a 100% viability guarantee or full refund. For parents who want a human being to call and a bank that stands behind its work, this is the pick.
If budget is a real constraint but you won't compromise on accreditation, our best value pick starts at $249 enrollment with a price-lock guarantee that eliminates the fee-increase risk currently driving federal litigation against a competitor. It's the most financially transparent option in our lineup.
And if private storage isn't in your budget at all, our fifth pick offers a free public donation program that is AABB and FACT accredited and has a documented history of helping patients find life-saving transplant matches. Donating publicly is a genuinely meaningful alternative, not a consolation prize.
More Picks We Love
Our full ranking, scored by our editorial team on safety, value, ease of use, and quality.

Vivos
Vivos is the strongest pick for parents who want to bank cord blood, cord tissue, and placenta tissue in a single collection — offering the broadest biological coverage at a competitive price.

ViaCord
ViaCord's 100% sample viability guarantee, dedicated family specialists, and 30+ years of AABB-accredited storage make it the top choice for parents who prioritize personal support and proven reliability.

Americord
Americord is the smartest pick for budget-conscious parents who refuse to compromise on accreditation — its price-lock guarantee eliminates the fee-increase risk that is currently at the center of industry litigation.

ViaCord
For families who want to give back or cannot afford private storage, ViaCord's free public donation program is AABB and FACT accredited and has helped hundreds of patients find life-saving transplant matches.
Frequently Asked Questions
Is cord blood banking actually worth the cost?▾
Cord blood banking provides a biological insurance policy — stored stem cells can be used to treat over 80 blood and immune system disorders, including certain leukemias and sickle cell disease. The probability of a child using their own banked cord blood is statistically low, but families with a history of blood disorders or those who want maximum future flexibility often find the cost justified. Public donation is a free alternative that benefits other patients if private storage isn't in your budget.
What is AABB accreditation and why does it matter?▾
AABB (formerly the American Association of Blood Banks) is an independent, internationally recognized accrediting body that audits cord blood banks on their collection, processing, testing, and storage standards. AABB accreditation is widely considered the minimum quality benchmark for private cord blood banking. All five banks in our ranking either hold AABB accreditation or are FDA-registered — we did not include any bank that lacks third-party quality oversight.
What is the lawsuit against CBR about, and should it change my decision?▾
As of early 2026, CBR faces a Texas AG lawsuit, an Arizona AG deceptive-practices lawsuit (whose motion to dismiss was denied in November 2025), and a federal class action investigation related to undisclosed storage fee increases. These proceedings do not indicate that stored samples are at risk, but they do raise legitimate concerns about fee transparency and business practices. Parents evaluating CBR should read the current fee schedule carefully, ask about rate-lock options, and weigh these regulatory developments alongside CBR's otherwise strong clinical track record.
When is the deadline to enroll in a cord blood bank?▾
Most banks recommend enrolling by week 28–34 of pregnancy — your third trimester — to ensure your collection kit arrives before your due date and your medical team is briefed on the collection procedure. Collection happens at birth and is a one-time opportunity; once the umbilical cord is discarded, the stem cells cannot be recovered. Enrolling early also gives you time to compare pricing, ask questions, and avoid rushed decisions.
What is the difference between cord blood and cord tissue banking?▾
Cord blood contains hematopoietic stem cells, which are currently used in transplants to treat blood and immune disorders. Cord tissue contains mesenchymal stem cells, which are being studied for potential applications in regenerative medicine, including treatments for neurological conditions and orthopedic injuries. Cord tissue banking is not yet as clinically established as cord blood banking, but banks like Vivos and Americord offer both in a single collection kit for families who want to preserve options as the science matures.
Ready to compare all options?
See every cord blood banks ranked by our editors — scored on safety, value, ease of use, and quality.
See all 5 Best Cord Blood Banks ranked →